SHZ Equity Snapshot

301281 Weekly Equity Report

Shandong Keyuan Pharmaceutical Co., Ltd.

Latest Close 46.43 CNY 12 Jun 2026
1W Return 6.7% latest completed week
4W Return 20.2% short-term follow-through
12W Return -5.1% quarterly tape
Trend Breadth 63.5% 33 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
Company Brief

What the company does

Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations. It offers gliclazide; metformin hydrochloride; isosorbide mononitrate; isosorbide dinitrate; lansoprazole; mecobalamin; ropivacaine hydrochloride; isoflurane; fluoxetine hydrochloride; clemastine fumarate; chlorpheniramine maleate; esmolol hydrochloride; nicotinamide-tinidazole; amlexanox; nisoldipine; qupibutu; clarithromycin lactobionate; propafenone hydrochloride; potassium diclofenac; chlorzoxazone; esomeprazole sodium; palonosetron hydrochloride; dalafeng; piroxicam; phenylephrine; vildagliptin; parecoxib sodium; ruxolitinib hydrochloride; and lurasidone hydrochloride. The company was founded in 2004 and is headquartered in Jinan, China.

Snapshot

What the weekly tape is saying

301281 closed the latest completed week at 46.43 CNY. The 4-week return is 20.2% and the 12-week return is -5.1%. Trend Signal is active, Market Dynamics is -0.04. Setup signature: Balanced read with a 69/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 28.4%
Volume 1.2x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 80 Persistence of active Trend Signal over the last year and current streak.
Momentum 92 Blend of 4-week and 12-week follow-through.
Dynamics 56 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 100 Relative leadership and short-term RS change.
Volume 50 Participation compared with the 13-week volume baseline.
Risk Control 37 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
36.17 CNY
Vs Trend Line
28.4%
Fair Value
32.04 CNY
Vs Fair Value
44.9%
52W High
53.99 CNY
52W Low
25.87 CNY
Drawdown
-14.0%
Range Position
73.1%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 6.7%
4W 20.2%
12W -5.1%
26W 66.1%
52W 34.3%

Trend read

Active Streak
14 weeks
52W Active Weeks
33
52W Active Breadth
63.5%
Sector Scope
CN Healthcare
Sector Rank
28 of 486
Sector Percentile
94.4%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.04
4W MD Change
83.9%
Relative Strength
16.12
4W RS Change
292.9%
Expectation
Negative
Probability
41.60%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
25.1M
13W Average
21.2M
52W Average
15.8M
Vs 13W
1.2x
Vs 52W
1.6x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
8.1%
52W Volatility
6.7%
Upside Weeks
27
Downside Weeks
24
Downside Breadth
46.2%
Avg Gain / Loss
5.3% / -4.3%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
SHZ
Country
CN
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
CNY
Market Cap
4.3B

Opportunity signals

  • Trend Signal is active with a 14-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 46.43 CNY 6.7% 36.17 CNY 32.04 CNY -0.04 16.12 25.1M On
5 Jun 2026 43.50 CNY 4.6% 35.67 CNY 31.92 CNY -0.19 6.08 26.6M On
29 May 2026 41.60 CNY 2.6% 35.28 CNY 31.82 CNY -0.27 -0.51 22.1M On
22 May 2026 40.55 CNY 5.0% 34.95 CNY 31.72 CNY -0.32 -3.72 15.8M On
15 May 2026 38.62 CNY -4.5% 34.67 CNY 31.62 CNY -0.25 -8.36 19.1M On
8 May 2026 40.44 CNY 7.3% 34.50 CNY 31.54 CNY -0.10 -4.42 13.8M On
1 May 2026 37.69 CNY 0.7% 34.30 CNY 31.44 CNY -0.05 -8.50 13.6M On
24 Apr 2026 37.42 CNY -2.1% 34.17 CNY 31.36 CNY 0.10 -8.48 21.0M On
17 Apr 2026 38.24 CNY 9.9% 34.05 CNY 31.30 CNY 0.38 -6.52 27.3M On
10 Apr 2026 34.79 CNY 2.1% 33.94 CNY 31.26 CNY 0.60 -11.77 16.6M On
3 Apr 2026 34.06 CNY -13.1% 33.95 CNY 31.23 CNY 0.97 -7.85 22.3M On
27 Mar 2026 39.20 CNY -19.9% 33.99 CNY 31.22 CNY 1.24 2.59 29.5M On
20 Mar 2026 48.95 CNY -1.3% 33.92 CNY 31.16 CNY 1.32 27.05 22.3M On
13 Mar 2026 49.61 CNY 13.3% 33.48 CNY 31.05 CNY 1.33 25.41 27.8M On